Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Retinoic Acid Receptor gamma Antibodies:
anti-Mouse (Murine) Retinoic Acid Receptor gamma Antibodies:
anti-Rat (Rattus) Retinoic Acid Receptor gamma Antibodies:
Go to our pre-filtered search.
Human Monoclonal Retinoic Acid Receptor gamma Primary Antibody for EMSA, IHC - ABIN2668712
Hoftijzer, Liu, Morreau, van Wezel, Pereira, Corssmit, Romijn, Smit: Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms. in European journal of endocrinology / European Federation of Endocrine Societies 2009
Show all 2 Pubmed References
the cytoplasmic retinoic acid receptor gamma (RARgamma) controls receptor-interacting protein (show RIPK1 Antibodies) kinase (show CDK7 Antibodies) 1 (RIP1 (show UQCRFS1 Antibodies))-initiated cell death when cellular inhibitor of apoptosis (cIAP) activity is blocked.
Results show that RARgamma expression is significantly upregulated in human hepatocellular carcinoma (HCC (show FAM126A Antibodies)) tissues and demonstrate that RARgamma could promote HCC (show FAM126A Antibodies) invasion and metastasis by regulating E-cadherin (show CDH1 Antibodies) reduction.
Dual small interfering RNA (siRNA) silencing of RARalpha (show RARA Antibodies) and RARgamma reversed RA blockade of P4-induced CK5 (show KRT5 Antibodies). Using promoter deletion analysis, we identified a region 1.1 kb upstream of the CK5 (show KRT5 Antibodies) transcriptional start site that is necessary for P4 activation and contains a putative progesterone response element (PRE
Loss of RARG expression is associated with Colorectal Tumorigenesis and Metastasis.
A nonsynonymous variant in RARG is highly associated with anthracycline-induced cardiotoxicity in childhood cancers.
deregulation of the retinoid/rexinoid signaling pathway has a major role and may represent a potential therapeutic target for NUP98 (show NUP98 Antibodies)-RARG-mediated transformation
The current status of knowledge indicates that there might be inter- or overlapping actions between PPARg (show PPARG Antibodies) and RARs (show RARS Antibodies), and there might be an association of PPARg (show PPARG Antibodies)/RARs (show RARS Antibodies)(RARa (show RARA Antibodies), RARb (show RARB Antibodies), and RARg) with renal diseases
RARgamma in concert with ATRA regulates protein levels of CDK1 (show CDK1 Antibodies) and its subcellular localization.
RARG plays an important role in the proliferation, metastasis, and chemoresistance of cholangiocarcinoma through simultaneous activation of the Akt (show AKT1 Antibodies)/NF-kappaB (show NFKB1 Antibodies) and Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) pathways.
Evidence that the retinoic acid receptor gamma plays a major role in the regulation of the human prostatic transglutaminase gene.
RARalpha (show RARA Antibodies) and RARgamma reciprocally control K5(+) progenitor cell proliferation and distribution in the developing submandibular salivary epithelium in a cell cycle-dependent manner while regulating lumenization independently of keratinizing differentiation
the reprogramming of epiblast stem cells into embryonic stem cell-like cells also requires low levels of retinoic acid (RA), which can modulate Wnt (show WNT2 Antibodies) signalling through physical interactions of RARs (show RARS Antibodies) with beta-catenin (show CTNNB1 Antibodies).
Data show that retinoic acid receptor gamma (RARgamma)-proto-oncogene protein c-fos (c-Fos)-PPARgamma2 (PPARgamma2 (show PPARG Antibodies)) signaling rather than reactive oxygen species generation is critical for all-trans retinoic acid (ATRA)-inhibited adipocyte differentiation.
RARgamma plays key roles in the differentiation competence of NGN3 (show NEUROG3 Antibodies)+ cells in response to retinoic acid during mouse spermatogenesis.
The results indicate a physiological role for RARgamma as a negative regulator of osteoclastogenesis in vivo and in vitro, and reveal distinct influences of RARalpha (show RARA Antibodies) and RARgamma in bone structure regulation.
this study shows that the combination of Rarg and Nr5a2 (show NR5A2 Antibodies) rapidly promote the iN cell maturation within 1 week and greatly facilitate the conversion with neuronal purities of approximately 50% and yields of >130%.
Data indicate that all three retinoic acid receptor (show RARA Antibodies) isoforms RARalha, RARbeta (show RARB Antibodies) and RARgamma are expressed in naive CD8 (show CD8A Antibodies)+ T cells, as well as CD8 (show CD8A Antibodies)+ T cells activated for 48 or 72 h.
erythroid-specific RAR (show RARA Antibodies) function is dispensable for erythropoiesis and RARgamma plays an erythroid extrinsic role in erythropoiesis.
Data indicate that male germ cell specific miR (show MLXIP Antibodies)-34c might be pivotal in embryonic stem cells (ESCs (show NR2E3 Antibodies)) differentiation into male germ cells through its target retinoic acid receptor gamma (RARg).
This gene encodes a retinoic acid receptor that belongs to the nuclear hormone receptor family. Retinoic acid receptors (RARs) act as ligand-dependent transcriptional regulators. When bound to ligands, RARs activate transcription by binding as heterodimers to the retinoic acid response elements (RARE) found in the promoter regions of the target genes. In their unbound form, RARs repress transcription of their target genes. RARs are involved in various biological processes, including limb bud development, skeletal growth, and matrix homeostasis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
retinoic acid receptor, gamma
, retinoic acid receptor gamma-like
, retinoic acid receptor gamma
, nuclear receptor subfamily 1 group B member 3
, retinoic acid nuclear receptor gamma variant 1
, retinoic acid nuclear receptor gamma variant 2
, RAR gamma 2
, RAR-gamma 2.1
, rar gamma
, retinoic acid receptor gamma isoform 2.1